Anti-Gripe Asclépius

Anti-Gripe Asclépius may be available in the countries listed below.

Ingredient matches for Anti-Gripe Asclépius

Paracetamol

Paracetamol is reported as an ingredient of Anti-Gripe Asclépius in the following countries:

• Portugal

International Drug Name Search

Benpéridol

Benpéridol may be available in the countries listed below.

Ingredient matches for Benpéridol

Benperidol

Benpéridol (DCF) is also known as Benperidol (Rec.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saroten

Saroten may be available in the countries listed below.

Ingredient matches for Saroten

Amitriptyline

Amitriptyline is reported as an ingredient of Saroten in the following countries:

• Taiwan

Amitriptyline hydrochloride (a derivative of Amitriptyline) is reported as an ingredient of Saroten in the following countries:

• Austria


• Bahrain


• Bangladesh


• Denmark


• Egypt


• Estonia


• Germany


• Greece


• Iceland


• Iran


• Iraq


• Jordan


• Kuwait


• Latvia


• Lebanon


• Oman


• Qatar


• Russian Federation


• Saudi Arabia


• Sri Lanka


• Sudan


• Sweden


• Switzerland


• United Arab Emirates


• Yemen

International Drug Name Search

Doc Fluconazol

Doc Fluconazol may be available in the countries listed below.

Ingredient matches for Doc Fluconazol

Fluconazole

Fluconazole is reported as an ingredient of Doc Fluconazol in the following countries:

• Belgium

International Drug Name Search

Marovilina

Marovilina may be available in the countries listed below.

Ingredient matches for Marovilina

Ampicillin

Ampicillin trihydrate (a derivative of Ampicillin) is reported as an ingredient of Marovilina in the following countries:

• Mexico

International Drug Name Search

Zantac 300

See also: Generic Zantac, Generic Zantac 150

Zantac 300 is a brand name of ranitidine, approved by the FDA in the following formulation(s):

ZANTAC 300 (ranitidine hydrochloride - tablet; oral)

• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: December 9, 1985
  
  Strength(s): EQ 300MG BASE ^[RLD][AB]

Has a generic version of Zantac 300 been approved?

Yes. The following products are equivalent to Zantac 300:

ranitidine hydrochloride tablet; oral

• 
  Manufacturer: AMNEAL PHARMS NY
  
  Approval date: October 13, 2006
  
  Strength(s): EQ 300MG BASE ^[AB]


• 
  Manufacturer: APOTEX
  
  Approval date: September 12, 1997
  
  Strength(s): EQ 300MG BASE ^[AB]


• 
  Manufacturer: DR REDDYS LABS INC
  
  Approval date: July 27, 2005
  
  Strength(s): EQ 300MG BASE ^[AB]


• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: November 19, 2008
  
  Strength(s): EQ 300MG BASE ^[AB]


• 
  Manufacturer: IVAX SUB TEVA PHARMS
  
  Approval date: September 30, 1998
  
  Strength(s): EQ 300MG BASE ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: August 22, 1997
  
  Strength(s): EQ 300MG BASE ^[AB]


• 
  Manufacturer: PAR PHARM
  
  Approval date: January 28, 1999
  
  Strength(s): EQ 300MG BASE ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: August 29, 1997
  
  Strength(s): EQ 300MG BASE ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: July 31, 1997
  
  Strength(s): EQ 300MG BASE ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: October 20, 1997
  
  Strength(s): EQ 300MG BASE ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: December 19, 2005
  
  Strength(s): EQ 300MG BASE ^[AB]


• 
  Manufacturer: WOCKHARDT
  
  Approval date: December 17, 1998
  
  Strength(s): EQ 300MG BASE ^[AB]


• 
  Manufacturer: WOCKHARDT
  
  Approval date: December 11, 2009
  
  Strength(s): EQ 300MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zantac 300. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Zantac 300.

See also...

• Zantac 300 Consumer Information (Cerner Multum)
• Ranitidine Consumer Information (Drugs.com)
• Ranitidine Consumer Information (Wolters Kluwer)
• Ranitidine Effervescent Tablets Consumer Information (Wolters Kluwer)
• Ranitidine Syrup Consumer Information (Wolters Kluwer)
• Ranitidine Tablets Consumer Information (Wolters Kluwer)
• Ranitidine Consumer Information (Cerner Multum)
• Ranitidine Hydrochloride AHFS DI Monographs (ASHP)

Analginas L

Analginas L may be available in the countries listed below.

Ingredient matches for Analginas L

Metamizole

Metamizole is reported as an ingredient of Analginas L in the following countries:

• Lithuania

International Drug Name Search

Diphenidol Hydrochloride

Diphenidol Hydrochloride may be available in the countries listed below.

Ingredient matches for Diphenidol Hydrochloride

Difenidol

Diphenidol Hydrochloride (USAN) is also known as Difenidol (Rec.INN)

International Drug Name Search

Glossary

Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Allernix

Allernix may be available in the countries listed below.

Ingredient matches for Allernix

Diphenhydramine

Diphenhydramine hydrochloride (a derivative of Diphenhydramine) is reported as an ingredient of Allernix in the following countries:

• Canada

International Drug Name Search

Zoamco

Zoamco may be available in the countries listed below.

Ingredient matches for Zoamco

Atorvastatin

Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Zoamco in the following countries:

• Vietnam

International Drug Name Search

Broncoxol

Broncoxol may be available in the countries listed below.

Ingredient matches for Broncoxol

Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Broncoxol in the following countries:

• Ecuador

International Drug Name Search

B & O Supprettes Suppositories

Pronunciation: bell-a-DON-a/OH-pee-um
Generic Name: Belladonna Alkaloids/Opium
Brand Name: B & O Supprettes

B & O Supprettes Suppositories are used for:

Treating moderate to severe pain due to spasms of the urinary tract.

B & O Supprettes Suppositories are an anticholinergic and analgesic combination. It works by relaxing the smooth muscle of the urinary tract and relieving pain.

Do NOT use B & O Supprettes Suppositories if:

• you are allergic to any ingredient in B & O Supprettes Suppositories


• you are in premature labor


• you have severe bowel motility problems (eg, paralytic ileus), severe diarrhea associated with antibiotic use (pseudomembranous colitis), glaucoma, severe liver or kidney disease, bronchial asthma or severe breathing problems, or a seizure disorder


• you have alcohol-withdrawal symptoms or you are taking sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.

Before using B & O Supprettes Suppositories:

Some medical conditions may interact with B & O Supprettes Suppositories. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of asthma, chronic obstructive pulmonary disease (COPD), or other lung or breathing problems


• if you have a history of recent head injury, increased pressure in the brain, brain blood vessel problems, growths in the brain (eg, tumors), or seizures


• if you have a history of heart problems, low blood pressure, liver or kidney problems, an underactive thyroid, adrenal gland problems (eg, Addison disease), stomach or bowel problems, gallbladder problems, inflammation of the pancreas, a blockage of the bladder or bowel, an enlarged prostate, or the blood disease porphyria


• if you have a history of substance or alcohol abuse, mood or mental problems, or suicidal thoughts or behavior

Some MEDICINES MAY INTERACT with B & O Supprettes Suppositories. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Cimetidine, furazolidone, monoamine oxidase (MAO) inhibitors (eg, phenelzine), phenothiazines (eg, chlorpromazine), or sodium oxybate (GHB) because the risk of side effects, such as severe drowsiness, slow or difficult breathing, confusion, and seizures, may be increased


• Buprenorphine, butorphanol, nalbuphine, naltrexone, or pentazocine because the effectiveness of B & O Supprettes Suppositories may be decreased

This may not be a complete list of all interactions that may occur. Ask your health care provider if B & O Supprettes Suppositories may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use B & O Supprettes Suppositories:

Use B & O Supprettes Suppositories as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Remove the wrapper and moisten the suppository with cool water. Lie down on your side. Insert the pointed end of the suppository into the rectum, then use your finger to push it in completely. Wash your hands thoroughly after using B & O Supprettes Suppositories.


• Do not exceed the recommended dose or take B & O Supprettes Suppositories for longer than prescribed without checking with your doctor. Exceeding the recommended dose or taking B & O Supprettes Suppositories for longer than prescribed may be habit-forming.


• If you miss a dose of B & O Supprettes Suppositories and you are using it regularly, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use B & O Supprettes Suppositories.

Important safety information:

• B & O Supprettes Suppositories may cause drowsiness, dizziness, or blurred vision. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to B & O Supprettes Suppositories. Using B & O Supprettes Suppositories alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.


• Avoid drinking alcohol or taking other medications that cause drowsiness (eg, sedatives, tranquilizers) while taking B & O Supprettes Suppositories. B & O Supprettes Suppositories will add to the effects of alcohol and other depressants. Ask your pharmacist if you have questions about which medicines are depressants.


• B & O Supprettes Suppositories may cause dizziness, lightheadedness, or fainting. Alcohol, hot weather, exercise, and fever can increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Also, sit or lie down at the first sign of dizziness, lightheadedness, or weakness.


• Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using B & O Supprettes Suppositories.


• Use B & O Supprettes Suppositories with caution in the ELDERLY because they may be more sensitive to its effects


• B & O Supprettes Suppositories are not recommended for use in CHILDREN younger than 12 years of age. Safety and effectiveness in this age group have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant while taking B & O Supprettes Suppositories, discuss with your doctor the benefits and risks of using B & O Supprettes Suppositories during pregnancy. It is unknown if B & O Supprettes Suppositories are excreted in breast milk. If you are or will be breast-feeding while you are using B & O Supprettes Suppositories, check with your doctor or pharmacist to discuss the risks to your baby.

When used for long periods of time or at high doses, B & O Supprettes Suppositories may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if B & O Supprettes Suppositories stops working well. Do not take more than prescribed.

When used for long periods of time or at high doses, some people develop a need to continue taking B & O Supprettes Suppositories. This is known as DEPENDENCE or addiction.

If you suddenly stop taking B & O Supprettes Suppositories, you may experience WITHDRAWAL symptoms including anxiety; diarrhea; fever, runny nose, or sneezing; goose bumps and abnormal skin sensations; nausea; vomiting; pain; rigid muscles; rapid heartbeat; seeing, hearing, or feeling things that are not there; shivering or tremors; sweating; and trouble sleeping.

Possible side effects of B & O Supprettes Suppositories:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Blurred vision; constipation; difficulty urinating; dizziness; drowsiness; dry mouth; fast pulse; nausea; sensitivity to light; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); eye pain.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: B & O Supprettes side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include anxiety; clumsiness; coma; decreased sweating; difficulty swallowing; dry mouth; elevated body temperature; fever; foul-smelling breath; heart attack; hot, dry, flushed skin; hyperactivity; irritability; loss of consciousness; loss of coordination; pinpoint or dilated pupils; seizures; shock; slowed or difficult breathing; stupor.

Proper storage of B & O Supprettes Suppositories:

Store B & O Supprettes Suppositories at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Do not refrigerate. Store away from heat, moisture, and light. Do not store in the bathroom. Keep B & O Supprettes Suppositories out of the reach of children and away from pets.

General information:

• If you have any questions about B & O Supprettes Suppositories, please talk with your doctor, pharmacist, or other health care provider.


• B & O Supprettes Suppositories are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about B & O Supprettes Suppositories. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More B & O Supprettes resources

• B & O Supprettes Side Effects (in more detail)
• B & O Supprettes Use in Pregnancy & Breastfeeding
• B & O Supprettes Drug Interactions
• B & O Supprettes Support Group
• 2 Reviews for B & O Supprettes - Add your own review/rating

Compare B & O Supprettes with other medications

• Overactive Bladder

Milibis

Milibis may be available in the countries listed below.

Ingredient matches for Milibis

Glycobiarsol

Glycobiarsol is reported as an ingredient of Milibis in the following countries:

• Bahrain


• Cyprus


• Egypt


• Jordan


• Kuwait


• Lebanon


• Qatar


• Saudi Arabia


• United Arab Emirates

International Drug Name Search

Caliprene

Caliprene may be available in the countries listed below.

Ingredient matches for Caliprene

Pilocarpine

Pilocarpine hydrochloride (a derivative of Pilocarpine) is reported as an ingredient of Caliprene in the following countries:

• Mexico

International Drug Name Search

Domerid

Domerid may be available in the countries listed below.

Ingredient matches for Domerid

Domperidone

Domperidone maleate (a derivative of Domperidone) is reported as an ingredient of Domerid in the following countries:

• Ireland

International Drug Name Search

Sindolan

Sindolan may be available in the countries listed below.

Ingredient matches for Sindolan

Naproxen

Naproxen sodium salt (a derivative of Naproxen) is reported as an ingredient of Sindolan in the following countries:

• Ecuador

International Drug Name Search